关于TIM-3的新兴见解:肺癌免疫治疗策略的潜在免疫检查点
Omer Qutaiba B Allela1, Abdulkareem Shareef2, Ashok Kumar Bishoyi3
1College of Pharmacy, Alnoor University, Mosul, Iraq.
Immunological investigations
|October 27, 2025
概括
T细胞免疫球蛋白粘素-3 (TIM-3) 是肺癌中一种新的免疫检查点标. 阻止TIM-3可能会克服对当前免疫疗法的耐药性,并改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症研究 癌症研究
背景情况:
- 免疫检查点受体 (ICR) 是癌症治疗的点,但许多患者对免疫检查点抑制剂 (ICI) 没有反应.
- T细胞免疫球蛋白粘素-3 (TIM-3) 是一种新兴的免疫检查点分子,参与瘤免疫逃避和癌症进展.
研究的目的:
- 审查和综合当前关于TIM-3在肺癌中的作用数据.
- 探索TIM-3在肺癌中的临床和治疗意义.
主要方法:
- 对TIM-3在肺癌中的流行病学和分子研究的系统文献综述.
- 对TIM-3的遗传突变,表达模式和免疫机制的分析.
主要成果:
- TIM-3基因突变与增加肺癌易感性相关.
- 在肺癌患者的瘤和免疫细胞中提升了TIM-3表达.
- TIM-3 损害免疫反应,影响预后,并导致ICI 耐药性.
结论:
- 在肺癌中,TIM-3是克服免疫疗法耐药性的有希望的治疗标.
- 了解TIM-3法规可以指导未来的精准医学策略.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K


